CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 136 filers reported holding CULLINAN ONCOLOGY INC in Q2 2024. The put-call ratio across all filers is 0.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $952,336 | +64.2% | 55,888 | -1.8% | 0.01% | +25.0% |
| Q4 2023 | $580,076 | +96.4% | 56,926 | +74.4% | 0.00% | +100.0% |
| Q3 2023 | $295,320 | +353.8% | 32,632 | +439.6% | 0.00% | – |
| Q2 2023 | $65,076 | -63.8% | 6,048 | -56.8% | 0.00% | -100.0% |
| Q3 2022 | $180,000 | -86.8% | 14,015 | -86.9% | 0.00% | -87.5% |
| Q2 2022 | $1,368,000 | +739.3% | 106,690 | +587.2% | 0.01% | +700.0% |
| Q1 2022 | $163,000 | -11.4% | 15,526 | +30.3% | 0.00% | -50.0% |
| Q4 2021 | $184,000 | – | 11,916 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $80,689,227 | 20.93% |
| CHI Advisors LLC | 3,317,544 | $35,000,089 | 9.32% |
| Nextech Invest Ltd. | 1,221,145 | $12,883,080 | 5.12% |
| BVF INC/IL | 7,509,059 | $79,220,572 | 3.34% |
| TANG CAPITAL MANAGEMENT LLC | 809,231 | $8,537,387 | 1.24% |
| SVB FINANCIAL GROUP | 27,032 | $285,188 | 0.78% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 229,416 | $2,420,339 | 0.69% |
| Boxer Capital, LLC | 1,074,082 | $11,331,565 | 0.60% |
| Atom Investors LP | 107,193 | $1,130,886 | 0.56% |
| HighVista Strategies LLC | 79,918 | $843,135 | 0.50% |